Treatment of Hypercholesterolaemia With PCSK-9-Inhibitors in Denmark Assessment of Real-Life Data; Extent and Efficacy After the First Years of clinical Use

S. Mulverstedt; I. C. Klausen; M. H. Martinsen; H. Kanstrup; K. K. Thomsen; J. Bech; F. L. Henriksen; J. Knold; L. J. Andersen; L. H. Kobbelgaard; J. Theilade; J. Clausen; K. M. Yafasov; K. Egstrup; J. S. Jensen; M. Heitmann

doi:10.1016/j.atherosclerosis.2019.06.114

Treatment of Hypercholesterolaemia With PCSK-9-Inhibitors in Denmark Assessment of Real-Life Data; Extent and Efficacy After the First Years of clinical Use

S. Mulverstedt, I. C. Klausen, M. H. Martinsen, H. Kanstrup, K. K. Thomsen, J. Bech, F. L. Henriksen, J. Knold, L. J. Andersen, L. H. Kobbelgaard, J. Theilade, J. Clausen, K. M. Yafasov, K. Egstrup, J. S. Jensen, M. Heitmann

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Atherosclerosis
Vol/bind	287
Sider (fra-til)	E39-E40
ISSN	0021-9150
DOI	https://doi.org/10.1016/j.atherosclerosis.2019.06.114
Status	Udgivet - aug. 2019
Begivenhed	87th Congress of the European Atherosclerosis Society - Maastricht, Holland Varighed: 26. maj 2019 → 29. maj 2019

Konference

Konference	87th Congress of the European Atherosclerosis Society
Land/Område	Holland
By	Maastricht
Periode	26/05/2019 → 29/05/2019

Dokumenter og links

10.1016/j.atherosclerosis.2019.06.114

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Mulverstedt, S., Klausen, I. C., Martinsen, M. H., Kanstrup, H., Thomsen, K. K., Bech, J., Henriksen, F. L., Knold, J., Andersen, L. J., Kobbelgaard, L. H., Theilade, J., Clausen, J., Yafasov, K. M., Egstrup, K., Jensen, J. S., & Heitmann, M. (2019). Treatment of Hypercholesterolaemia With PCSK-9-Inhibitors in Denmark Assessment of Real-Life Data; Extent and Efficacy After the First Years of clinical Use. Atherosclerosis, 287, E39-E40. https://doi.org/10.1016/j.atherosclerosis.2019.06.114

@article{852bfeda43a64559b8c7f1b8c7752197,

title = "Treatment of Hypercholesterolaemia With PCSK-9-Inhibitors in Denmark Assessment of Real-Life Data; Extent and Efficacy After the First Years of clinical Use",

author = "S. Mulverstedt and Klausen, {I. C.} and Martinsen, {M. H.} and H. Kanstrup and Thomsen, {K. K.} and J. Bech and Henriksen, {F. L.} and J. Knold and Andersen, {L. J.} and Kobbelgaard, {L. H.} and J. Theilade and J. Clausen and Yafasov, {K. M.} and K. Egstrup and Jensen, {J. S.} and M. Heitmann",

year = "2019",

month = aug,

doi = "10.1016/j.atherosclerosis.2019.06.114",

language = "English",

volume = "287",

pages = "E39--E40",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier",

note = "87th Congress of the European Atherosclerosis Society ; Conference date: 26-05-2019 Through 29-05-2019",

}

Mulverstedt, S, Klausen, IC, Martinsen, MH, Kanstrup, H, Thomsen, KK, Bech, J, Henriksen, FL , Knold, J, Andersen, LJ, Kobbelgaard, LH, Theilade, J, Clausen, J, Yafasov, KM, Egstrup, K, Jensen, JS & Heitmann, M 2019, 'Treatment of Hypercholesterolaemia With PCSK-9-Inhibitors in Denmark Assessment of Real-Life Data; Extent and Efficacy After the First Years of clinical Use', Atherosclerosis, bind 287, s. E39-E40. https://doi.org/10.1016/j.atherosclerosis.2019.06.114

TY - ABST

T1 - Treatment of Hypercholesterolaemia With PCSK-9-Inhibitors in Denmark Assessment of Real-Life Data; Extent and Efficacy After the First Years of clinical Use

AU - Mulverstedt, S.

AU - Klausen, I. C.

AU - Martinsen, M. H.

AU - Kanstrup, H.

AU - Thomsen, K. K.

AU - Bech, J.

AU - Henriksen, F. L.

AU - Knold, J.

AU - Andersen, L. J.

AU - Kobbelgaard, L. H.

AU - Theilade, J.

AU - Clausen, J.

AU - Yafasov, K. M.

AU - Egstrup, K.

AU - Jensen, J. S.

AU - Heitmann, M.

PY - 2019/8

Y1 - 2019/8

U2 - 10.1016/j.atherosclerosis.2019.06.114

DO - 10.1016/j.atherosclerosis.2019.06.114

M3 - Conference abstract in journal

SN - 0021-9150

VL - 287

SP - E39-E40

JO - Atherosclerosis

JF - Atherosclerosis

T2 - 87th Congress of the European Atherosclerosis Society

Y2 - 26 May 2019 through 29 May 2019

ER -